Table 6 The sex-specific age-standardized prevalence rates of metabolic syndrome according to IDF definition and its individual components in two different periods (2009 and 2017), Jordan
| Â | 2017 | 2009 |
|---|---|---|
Age-standardized prevalence rate (95% CI) | Age-standardized prevalence rate (95% CI) | |
Metabolic syndrome | ||
 Male | 45.7 (42.9, 48.5) | 34.6 (31.4, 37.8) |
 Female | 44.5 (43.0, 46.1) | 39.8 (38.1, 41.5) |
 Total | 44 (42.7, 45.4) | 38.0 (36.5, 39.5) |
Central obesity | Â | Â |
 Male | 60.4 (57.6, 63.2) | 41.5 (38.0, 45.1) |
 Female | 75.6 (74.2, 77.0) | 60.1 (58.2, 61.9) |
 Total | 70.9 (69.6, 72.3) | 55.2 (53.5, 56.9) |
High fasting blood glucose | ||
 Male | 39.2 (36.6, 41.8) | 28.7 (25.8, 31.6) |
 Female | 32.4 (30.9, 33.9) | 23.9 (22.3, 25.5) |
 Total | 34.2 (32.9, 35.5) | 25.1 (23.7, 26.4) |
Elevated blood pressure | ||
 Male | 46.7 (44.0, 49.5) | 47.2 (43.5, 50.8) |
 Female | 37.7 (36.2, 39.2) | 38.6 (37.0, 40.3) |
 Total | 39.8 (38.5, 41.1) | 40.2 (38.7, 41.6) |
Elevated triglycerides | ||
 Male | 50.1 (47.3, 53.1) | 54.4 (50.4, 58.3) |
 Female | 35.1 (33.4, 36.7) | 40.0 (38.1, 42.0) |
 Total | 38.5 (37.1, 39.9) | 42.7 (41.0, 44.4) |
Low HDL | ||
 Male | 59.2 (56.2, 62.3) | 70.0 (66.1, 73.8) |
 Female | 57.4 (55.5, 59.2) | 64.7 (62.7, 66.7) |
 Total | 57.7 (56.1, 59.3) | 65.7 (64.0, 67.5) |
HDL high-density lipoprotein | Â | Â |